Clinical trials data
Verbal Fluency in obesity and diabetes trials: 63 registered studies
Every registered obesity and diabetes study on ClinicalTrials.gov that names Verbal Fluency in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered obesity and diabetes studies name it in an outcome measure
- 63
- Name it in a primary outcome, 48%
- 30 of 63
Tests named in the same studies
- 1
Trail Making Test34 studies, 16 as a primary outcome
- 2
Verbal Learning31 studies, 14 as a primary outcome
- 3
Stroop Color-Word Test20 studies, 13 as a primary outcome
- 4
Digit Span Test18 studies, 7 as a primary outcome
- 5
Category Fluency15 studies, 9 as a primary outcome
- 6
Symbol Coding12 studies, 10 as a primary outcome
- 7
Complex Figure Copy and Recall9 studies, 5 as a primary outcome
- 8
Card Sorting Test (Berg)6 studies, 4 as a primary outcome
- 9
Picture Naming Test6 studies, 4 as a primary outcome
- 10
Letter-Number Sequencing Task5 studies, 4 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 2 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 2 | 2 |
| 2015 | 1 | 1 |
| 2016 | 4 | 1 |
| 2017 | 2 | 2 |
| 2018 | 2 | 1 |
| 2019 | 7 | 4 |
| 2020 | 1 | 0 |
| 2021 | 6 | 1 |
| 2022 | 8 | 5 |
| 2023 | 2 | 1 |
| 2024 | 7 | 2 |
| 2025 | 11 | 6 |
| 2026 | 2 | 2 |
Phases and study sizes
By phase
- Phase 13 studies, 1 as a primary outcome
- Phase 26 studies, 4 as a primary outcome
- Phase 2/31 studies, 1 as a primary outcome
- Phase 43 studies, 0 as a primary outcome
- Not applicable33 studies, 14 as a primary outcome
- Observational17 studies, 10 as a primary outcome
Participants per study
- Not applicable52 median, 36 to 92
- Observational138 median, 100 to 400
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 33 | 52 | 36 to 92 |
| Observational | 17 | 138 | 100 to 400 |
When obesity and diabetes trials measure it
Latest time point of each outcome
- Within a day6 outcomes, 2 as a primary outcome
- Up to 4 weeks6 outcomes, 1 as a primary outcome
- 1 to 3 months17 outcomes, 7 as a primary outcome
- 3 to 6 months10 outcomes, 5 as a primary outcome
- 6 to 12 months9 outcomes, 7 as a primary outcome
- 1 to 2 years1 outcomes, 0 as a primary outcome
- Over 2 years9 outcomes, 5 as a primary outcome
- No duration given5 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
58 of the 63 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting15 studies, 7 as a primary outcome
- Not yet recruiting2 studies, 2 as a primary outcome
- Active, not recruiting6 studies, 3 as a primary outcome
- Completed32 studies, 15 as a primary outcome
- Stopped early5 studies, 2 as a primary outcome
- Status unknown3 studies, 1 as a primary outcome
What they test
- Behavioral18 studies, 8 as a primary outcome
- Drug15 studies, 8 as a primary outcome
- Device1 studies, 1 as a primary outcome
- Dietary supplement8 studies, 2 as a primary outcome
- Procedure4 studies, 0 as a primary outcome
- Other17 studies, 8 as a primary outcome
- None given12 studies, 9 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States31 studies, 12 as a primary outcome
- Spain8 studies, 4 as a primary outcome
- Denmark5 studies, 3 as a primary outcome
- Germany3 studies, 1 as a primary outcome
- United Kingdom3 studies, 0 as a primary outcome
- Canada2 studies, 0 as a primary outcome
- Chile2 studies, 0 as a primary outcome
- France2 studies, 0 as a primary outcome
- India2 studies, 1 as a primary outcome
- Mexico2 studies, 1 as a primary outcome
- Pakistan2 studies, 1 as a primary outcome
- Russia2 studies, 1 as a primary outcome
33 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed obesity and diabetes studies that name Verbal Fluency: 17 of 32, 53%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed obesity and diabetes studies that name Verbal Fluency | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 3, 9% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 22% | 1,139, 14% |
| A results paper only | 7, 22% | 1,711, 22% |
| Neither | 15, 47% | 4,327, 54% |
The 63 studies
63 studies match. 30 name Verbal Fluency in a primary outcome. Median size 80 participants. Median time to the primary outcome: 6 months.
Loading 63 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 2 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 2 | 2 |
| 2015 | 1 | 1 |
| 2016 | 4 | 1 |
| 2017 | 2 | 2 |
| 2018 | 2 | 1 |
| 2019 | 7 | 4 |
| 2020 | 1 | 0 |
| 2021 | 6 | 1 |
| 2022 | 8 | 5 |
| 2023 | 2 | 1 |
| 2024 | 7 | 2 |
| 2025 | 11 | 6 |
| 2026 | 2 | 2 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 4, NIH 1, other 58. Interventional 46, observational 17.
As a primary outcomeSecondary or other outcomeVerbal Fluency
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07694596 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants200 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07414914 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07374705 | Start2026 | PhaseObservational | ConditionsObesity and diabetes | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07371325 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Obesity and diabetes | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07284316 | Start2025 | PhasePhase 2/3 | ConditionsObesity and diabetes | Participants100 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07164768 | Start2024 | PhaseObservational | ConditionsObesity and diabetes | Participants400 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07140445 | Start2025 | PhaseObservational | ConditionsObesity and diabetes | Participants175 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07040748 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants84 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06968728 | Start2025 | PhaseObservational | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants400 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06869941 | Start2025 | PhaseObservational | ConditionsObesity and diabetes | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06867198 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes, Cardiovascular disease | Participants72 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06857994 | Start2025 | PhaseObservational | ConditionsObesity and diabetes, Cardiovascular disease | Participants101 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06819371 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06781762 | Start2025 | PhaseObservational | ConditionsCancer, Obesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06735651 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06735599 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes, Cardiovascular disease | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06649981 | Start2025 | PhasePhase 1 | ConditionsObesity and diabetes | Participants80 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06496412 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06471634 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise, Obesity and diabetes, Sleep and sleep disorders | Participants44 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06317883 | Start2019 | PhaseObservational | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants1,508 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06243172 | Start2024 | PhaseObservational | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06069739 | Start2016 | PhaseNot applicable | ConditionsObesity and diabetes | Participants29 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05997316 | Start2023 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants33 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05841173 | Start2022 | PhaseNot applicable | ConditionsObesity and diabetes | Participants200 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05658354 | Start2022 | PhaseNot applicable | ConditionsObesity and diabetes | Participants50 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many obesity and diabetes trials use Verbal Fluency?
63 registered obesity and diabetes studies on ClinicalTrials.gov name it in an outcome measure, 30 of them in a primary outcome: 10% of the condition's 627 studies with a cognitive outcome, against 11% of all of them. It is the 5th most named test in obesity and diabetes trials.
Which tests do obesity and diabetes trials use with Verbal Fluency?
The Trail Making Test (34 studies), Verbal Learning (31 studies) and the Stroop Color-Word Test (20 studies).
When do obesity and diabetes trials measure Verbal Fluency?
Half of the primary outcomes that name Verbal Fluency are measured within 6 months of the start, and the middle half from 12 weeks to 12 months. 27 primary outcomes give a duration.
How many completed obesity and diabetes trials that use Verbal Fluency have reported results?
17 of the 32 completed studies that name it, 53%, have reported results: 10 posted them on ClinicalTrials.gov, 10 have a results paper linked to the registry record, and 3 did both. The other 15 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Verbal Fluency in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.